Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C.
about
Surveillance for hepatocellular carcinoma.Hepatocellular carcinoma: a reviewAsian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Ultrasound elastography for fibrosis surveillance is cost effective in patients with chronic hepatitis C virus in the UKHepatocellular carcinoma in patients with chronic hepatitis C virus infection without cirrhosis.The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations.Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosisCancer screening in renal transplant recipients: what is the evidence?Comparative effectiveness of donation after cardiac death versus donation after brain death liver transplantation: Recognizing who can benefit.Surveillance of cirrhosis for hepatocellular carcinoma: a cost-utility analysisCost-effectiveness analysis of population-based screening of hepatocellular carcinoma: Comparing ultrasonography with two-stage screening.Management of solitary 1 cm to 2 cm liver nodules in patients with compensated cirrhosis: a decision analysis.Surveillance for hepatocellular carcinoma in chronic liver disease: evidence and controversiesModern approach to hepatocellular carcinoma.Incidence and Determinants of Hepatocellular Carcinoma in Autoimmune Hepatitis: A Systematic Review and Meta-analysis.Tailored algorithms for hepatocellular carcinoma surveillance: Is one-size-fits-all strategy outdated?Surveillance of the Patients with High Risk of Hepatocellular Cancer.Screening process failures for hepatocellular carcinoma.Cost-effectiveness of the surveillance program of hepatocellular carcinoma depends on the medical circumstances.Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United States.Risk of hepatocellular carcinoma among individuals with different aetiologies of cirrhosis: a population-based cohort study.Hospitalized Patients with Cirrhosis Should Be Screened for Clostridium difficile Colitis.Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.Surveillance for hepatocellular carcinoma: in whom and how?Risk factors for early-onset and late-onset hepatocellular carcinoma in Asian immigrants with hepatitis B in the United States.A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis.The prevalence of atherosclerosis in cirrhotic patients: assessment of two aspects of atherosis and sclerosis.Cost-effectiveness analysis on the surveillance for hepatocellular carcinoma in liver cirrhosis patients using contrast-enhanced ultrasonography.Resource utilization and survival among Medicare patients with advanced liver disease.HBsAg loss in a New Zealand community study with 28-year follow-up: rates, predictors and long-term outcomes.The Diagnostic Performance of Liver MRI without Intravenous Contrast for Detecting Hepatocellular Carcinoma: A Case-Controlled Feasibility Study.Hepatocellular carcinomaScreening for hepatocellular carcinoma: The rationale for the American Association for the Study of Liver Diseases recommendations
P2860
Q27690269-5FC25FAF-1BD2-4691-9C25-15322A08071CQ28069290-F709D6BD-E3C6-41D3-BFA7-ECD8B1BCFCA6Q30391932-6CCEBE56-423E-4E60-B151-06E7784A3BFFQ33795154-B5292082-6E9A-40DD-B1E5-91DA01F1B2F0Q34084962-1F886332-1813-49CE-BEFD-0E9D5B48A2F9Q34826535-95AFFFC6-C2D0-4DBB-A13B-0C2325CF31DBQ35122619-7C62C2AE-EAF3-4495-91F8-85DEA2F84B2EQ35153329-EF7CDD26-91E3-4CC1-9709-59761462929CQ36003299-1E868A51-9A8D-4650-94B4-236DA02B52C1Q36608549-F34D2EFA-F6B5-4CB3-9E55-1AE9A2D861D0Q36724410-6B3AC735-3AEB-4C39-91E4-22964D152398Q36912160-4B8D8C57-8CA2-457A-A14D-7984C611B705Q37266376-833DD35C-5AF1-4FDB-827E-4EE9D450DB6FQ37812000-E2B1BA41-B7B8-44F8-9951-6CFC8FD09E10Q39142806-101F068F-3C8D-4CDD-8BF2-F6176FA57D7AQ39197775-7A0D3DC0-A714-4C95-B3ED-7DBB95F64FBCQ39387245-E6158B46-B3CD-474C-865D-9B42DA170ED7Q40176654-DCF54C54-ED3E-4B1D-9FB8-662D0E8E5A70Q40185773-54285F76-A299-47AC-BBE6-927E12150855Q40345258-D035C280-58AB-4F42-9CE2-9DADAA292645Q40356341-2A4CAB82-3E93-464B-BD7B-5FCCC12C8003Q40926881-A977BB37-32DE-48B5-9969-5FAF57DB85A1Q41962614-5CBCA194-B09B-4CD2-9596-D15E1EC7AA33Q42593959-B6AC990A-C1CF-40B3-8B9A-C315D1F6D294Q44747629-872F6F61-98EF-439C-BFDD-5F9AADCBFCE1Q45415153-1839D87A-DAEF-4586-AAA5-DFC358333ABCQ50697196-2F7AEB6A-C44E-458A-AD0F-D909CD40B64AQ51175477-5390F3BC-3718-4601-84E1-E75B70345ADCQ53085800-D838440A-3FBE-40AB-B1A5-229C7CEB55CCQ53153341-D6DBAFD8-4A4E-47B1-BD93-24E5D5C2CD8DQ55424498-366F187E-330C-4853-9B43-452AB36163F3Q57756376-4B6FA3A4-F0AA-41B8-B936-70659E58108CQ58021206-F9581616-6480-4CEC-BEF6-2745829FC2E5
P2860
Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Cost-effectiveness of screenin ...... is due to chronic hepatitis C.
@en
Cost-effectiveness of screenin ...... is due to chronic hepatitis C.
@nl
type
label
Cost-effectiveness of screenin ...... is due to chronic hepatitis C.
@en
Cost-effectiveness of screenin ...... is due to chronic hepatitis C.
@nl
prefLabel
Cost-effectiveness of screenin ...... is due to chronic hepatitis C.
@en
Cost-effectiveness of screenin ...... is due to chronic hepatitis C.
@nl
P2093
P2860
P1476
Cost-effectiveness of screenin ...... is due to chronic hepatitis C.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2036.2004.01963.X
P407
P577
2004-06-01T00:00:00Z